On November 9, 2020, Synalloy Corp. announced the acquisition of DanChem, a leading full-service specialty chemicals manufacturer, for approximately $1.2 billion.  According to the company's press release announcing the acquisition, DanChem is uniquely positioned to be a leader in the specialty chemicals business.  The company's Board of Directors previously approved the acquisition.  According to the SEC's complaint filed in federal court in the District of Columbia, DanChem is uniquely positioned to be the premier solution provider through best in class safety, quality and customer experience.  According to the SEC's complaint, DanChem's capacity to produce high-quality, high-quality products is limited by supply chain and labor constraints.  The SEC's complaint alleges that DanChem's capacity to produce high-quality products is limited by the capacity of its plants.  The SEC's complaint, filed in federal district court in the District of Columbia, charges DanChem with violating the antifraud provisions of Section 17(a) of the Securities Act of 1933 and Section 10(b) of the Securities Exchange Act of 1934 and Rule 10b-5 thereunder.  Without admitting or denying the allegations in the SEC's complaint, DanChem has agreed to the entry of a final judgment that permanently enjoins it from violating the antifraud provisions of the federal securities laws.  The settlement is subject to court approval.  The SEC's investigation, which is continuing, has been conducted by Ben Rosenzweig, Chris Hutter, and Aaron Tam of the SEC's Market Abuse Unit.  The litigation will be led by Mr. Rosenzweig and Mr. Tam.  The SEC appreciates the assistance of the U.S. Attorney's Office for the District of Columbia and the Federal Bureau of Investigation.  The SEC's Office of Investor Education and Advocacy has issued anÂ Investor AlertÂ to encourage investors to check the background of anyone selling or offering them an investment using the free and simple search tool onÂ Investor.gov.